The presentation of the Minister for Social Affairs and Health of the Minister for Social Affairs of 25 July 1986 (583/86), Article 7 (2), Article 10 (3), Article 20 (1), Article 33 and Article 41:

ARTICLE 1 (30.12.2003/1383)

Paragraph 1 has been repealed by A 30.12.2003/1383 .

ARTICLE 2 (23.7.2009)

General dangerous infectious diseases Are:

Ehec-infection

Hepatitis A

Influenza A virus subtype H5N1

Smallpox

Yellow fever

Cholera

Syphilis

Diphtheria

Typhoid, typhoid fever and other diseases caused by salmonella

Meningococcal septic diseases and meningitis

Anthrax

Polio

Plague

Sars

Shigellosis disease

Tuberculosis and

Haemorrhagic fevers from viruses,

Not yet myr fever.

Notifiable infectious diseases Are:

Botulism

New variant Creutzfeldt-Jakob disease

Echinococcosis

Septic diseases and meningitis caused by haemophilia

Hepatitis B

Hepatitis C

Whooping cough

Hiv infection

Sexually transmitted chlamydia infections

Legionellosis

Listeriosis

Malaria

Other mycobacterial diseases other than tuberculosis

Wood-like encephalitis

Rabies

Hackers

Mumps

Gonorrhea

Measles and

The rubella.

ARTICLE 3 (30.12.2003/1383)

The Ministry of Social Affairs and Health will be in infectious diseases. (183/1986) Within the meaning of the law referred to therein:

(1) ensure the implementation of the health education necessary to combat communicable diseases in the population, as well as national information;

(2) to monitor and promote scientific research into and its application in our country and in the field of combating international communicable diseases; and

3) perform the other tasks assigned to the Ministry of Social Affairs and Health for the purpose of preventing infectious diseases.

§ 4 (29.12.2009)

In addition to the tasks referred to in the said Law, the Regional Administrative Agency shall:

(1) monitoring the communicable disease situation within its territory;

(2) to plan and direct the fight against communicable diseases within its territory and to monitor compliance with the relevant provisions and regulations;

(3) make representations to the Ministry of Social Affairs and Health, where appropriate, on the prevention of communicable diseases;

(4) perform the tasks assigned or assigned to the Regional Administrative Agency for the purpose of the prevention of communicable diseases.

§ 5 (30.12.2003/1383)

In addition to the tasks referred to in the said Law, the hospital becomes responsible for:

(1) ensure that specialised medical care services are available for the treatment of infectious diseases in the area of nursing care;

(2) organise the necessary training in the treatment of communicable diseases in the health care centre;

(3) contribute to the development of the fight against communicable diseases in the area of medical care;

(4) provide, on request, to the doctor responsible for the communicable diseases of the health centre, taking into account the restrictions on disclosure of Article 10 (3) of the information contained in Article 10 (3) summaries of the communicable diseases which are registered at the health centre; The area; and

5) provide information on regional communicable diseases to healthcare professionals.

ARTICLE 6 (30.12.2003/1383)

In addition to the tasks referred to in that law, the doctor responsible for the prevention of communicable diseases and the health centre responsible for communicable diseases of the Centre shall, for its part, be responsible for:

(1) take care of the work of the health centre in the field of the fight against communicable diseases, including information on communicable diseases, health education and health advice, including intravenous health advice and infectious diseases; Where necessary, the replacement of the means of use;

(2) ensure that a person who is ill or suspected of being infected with a universal infectious disease is being investigated;

(3) undertake, where appropriate, measures for the organisation of treatment for the affected infectious disease;

(4) take any other necessary or specific measures for the prevention of a dangerous infectious disease; and

(5) carry out specific or specific tasks for the prevention of communicable diseases.

§ 7 (30.12.2003/1383)

The health and welfare institution shall: (29.12.2009)

Paragraph 1 has been repealed by A 21.12.2006/1376 .

Paragraph 2 is repealed by A 21.12.2006/1376 .

Paragraph 3 has been repealed by A 21.12.2006/1376 .

(4) monitoring the fight against communicable diseases and making representations to the Ministry of Social Affairs and Health on the prevention of communicable diseases;

(5) carry out scientific research on communicable diseases and carry out and develop laboratory studies necessary for the prevention of communicable diseases;

(6) provide for national information on communicable diseases;

(7) to provide expertise to the institutions responsible for the fight against communicable diseases in the municipalities and to medical care professionals in the detection of infectious epidemics;

(8) organise training in the fight against communicable diseases;

(9) provide information on the current status of communicable diseases to medical centres, laboratories and health centres, and provide information to the Ministry of Social Affairs and Health, the Regional Administrative Agencies, the Defence Forces, the Border Guard and the International The exchange of infectious disease data; (29.12.2009)

(10) participate in national and international cooperation in the fight against communicable diseases; and

(11) perform the other tasks assigned to it by the Ministry of Social Affairs and the Ministry of Social Affairs and Health.

§ 8 (30.12.2003/1383)

§ 8 has been repealed by A 30.12.2003/1383 .

§ 9 (30.12.2008/1107)

The vaccine should only be injected by a doctor and any other healthcare professional who has received appropriate training under the supervision of a doctor.

ARTICLE 10 (30.12.2003/1383)

The doctor or dentist shall submit an infectious disease declaration (hereinafter referred to as: A medical infectious disease notification; , other than pertussis, other salmonellosis other than typhoid or typhoid, tick-borne encephalitis, septic diseases caused by haemophilia and meningitis, sexually transmitted diseases And other mycobacterial infections other than tuberculosis and the new variant of Creutzfeldt-Jakob disease. However, a dentist can control patients with infectious diseases in order to make a diagnosis to a doctor's office when a doctor makes a declaration of infection. In addition to the information identified in Article 23 of the infectious disease report, the medical report contains information on the patient's gender, the municipality of residence and nationality, the place of treatment, the infection, the date of onset of symptoms and The criteria for diagnosis. In addition, the notifier shall subscribe to the notification and contact details. (21.12.2006)

A medical transmissible disease notification shall be made within seven days of the confirmation of the case. In cases of particular urgency, the medical practitioner must immediately notify the doctor responsible for the communicable diseases of the health centre and the medical centre and the health and welfare institution. The initial notification of the telephone shall be confirmed by a written declaration of infection in the event of confirmation of the case. The notification of tuberculosis must be made both when the infection has been detected and the treatment has been completed. (29.12.2009)

The hiv infection is reported at the time of infection at the time of infection, when the disease reaches the AIDS stage and the patient dies. An estimate of the time and method of infection, the cause of death and whether blood has been donated by the infected person shall be included in the hiv infection declaration. The health and welfare institution may disclose information to the doctor responsible for communicable diseases of the health centre only without the identity of the person concerned. (30.12.2008/1107)

Article 10a (30.12.2003/1383)

The laboratory shall report an infectious disease notification of the findings of a generic and notifiable infectious disease agent and other microbial nuclear registrations. Other registered microbial nuclear items are listed in Annex 1.

The register of micro-medicinal products which are highly resistant to regional medicinal products shall be entered in the register of the applicants for highly resistant microbes in Article 23 (3) and Article 23a (4), as well as the information referred to in Articles 10 and 10b of this Regulation on the following carriers:

1) Escherichia coli or Klebsiella pneumoniae with reduced sensitivity to knee cephalosporins (ESBL);

2) Methicillin/oxacillin resistant Staphylococcus aureus (MRSA);

3) Vancomycin-resistant enterococci (VRE); and

4) Staphylococci resistant to Vancomycin.

(30.12.2008/1107)

Article 10b (30.12.2003/1383)

In addition to the information identified in Article 23 of the communicable disease report, the cdc contains information on the location, date of sampling, the study finding, the method of detection of the microbe, the quality of the sample, and The name of the reporting laboratory. If a sample has been sent from a non-reporting laboratory or sent to another laboratory, these names shall also be indicated. Salmonella, shigella and Campylobacter infections must be reported in the case of infection. All infectious diseases in the laboratory shall also include the name of the reporting laboratory. Where the finding of the laboratory refers to a case of infection which the treating physician is obliged to submit to an infectious disease report, the laboratory shall attach to its own reply to this note.

The infectious disease declaration must be submitted no later than three days after confirmation of the finding.

Article 10c (21.12.2006)

All information on the communicable disease reports shall be kept to the end of the aggregation of the separate declarations of the same infectious disease case (hereinafter referred to as: Interconnecting time interval Until the end of the following year. After this, the registry data will be removed from the patient's name and the identification number will be changed to a form in which it cannot be identified.

The interval shall be 50 years in the case of typhoid, typhoid, syphilis, tuberculosis, hepatitis B, hepatitis C, hiv infection, other mycobacterial disease other than tuberculosis, hepatitis D virus disease, HTL virus disease, A new variant of Creutzfeldt-Jakob disease, or methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant staphylococcus (VRSA), resistant enterococci (VRE) or III generation Escherichia, decreased susceptibility to cephalosporins Infection caused by Coli or Klebsiella pneumoniae, with the exception of septic infections and meningitis. (13.12.2007)

The combination period shall be three years in the case of echinococcosis, malaria, Borrelia burgdorferi, brucella, fungal or parasitic evidence of blood or spinal fluid, filaria and skistosoma.

The interval shall be three months in the case of septic disease caused by meningococcus or meningitis, gonorrhea, clostridium difficile, haemophilia, MRSA, MRSA, VRA, VRE or III generation cephalosporins Septic disease and meningitis caused by Escherichia coli or Klebsiella pneumoniae strain, sexually transmitted chlamydia, soft vocabulary, other bacterial or viral findings of blood and spinal fluid, or astrovirus, Influenza virus, parain-fluenza virus, calicivirus (contains Norovirus), syncytial virus, rhinovirus and rotavirus disease. (13.12.2007)

In all other infectious diseases, the interconnector shall be 12 months.

ARTICLE 11 (30.12.2003/1383)

The employer shall require the worker, within the functions referred to in Article 20 of the communicable disease, to report that the worker is not sick of salmonellosis or respiratory tuberculosis. The report on the fact that a worker is not sick of salmonellosis must also be required for a person who is working for milk processing on a dairy farm whose milk goes for consumption without pasteurisation.

ARTICLE 12 (30.12.2003/1383)

In accordance with Article 23 (2) of the sticker, the laboratory's communicable disease declaration must be accompanied by microbial strains or samples in accordance with Annex 2.

ARTICLE 13 (30.12.2008/1107)

The contagious diseases referred to in Article 23c (2) of the municipal veterinary authority referred to in Article 23c (2) are:

(1) rabies and suspicion;

2) anthrax and suspicion;

3) brucellosis-infected;

4) Mycobacterium bovis;

5) Burkholder (Pseudomonas) malt;

(6) psittacosis;

(7) the ehec infection in a person who has been in contact with farmed animals at home;

(8) Salmonella infection, Q fever or leptospirosis in a person who lives or works on farm animals;

(9) trichinosis;

10) botulism and suspicion.

ARTICLE 14

If a person who is to be removed from a State institution within the meaning of Article 9 of the communicable disease is in need of treatment due to an epidemic or an infectious disease, he shall be provided at the expense of the State at the expense of the State The place of treatment.

ARTICLES 15 TO 17

Articles 15 to 17 have been repealed by A 30.12.2003/1383 .

ARTICLE 18

This Regulation shall enter into force on 1 January 1987.

Before the entry into force of this Regulation, measures may be taken to implement it.

The other types of microbial nuclear material referred to in Article 10 of the TCD Regulation are all microbes found in blood or spinal fluid and in addition:

Bacteria:

Bordetella pertussis

Borrelia burgdorferi

Borrelia recurrentis

Brusellat

Chlamydia pneumoniae

Chlamydia psittaci

Clostridium difficile

Coxiella burnetii

Enterobacter cloacae (strains with reduced susceptibility to carbapenems or resistant to carbapenems)

Enter vaccines (vancomycin resistant strains, VRE)

Escherichia coli (strains with reduced sensitivity to the cephalosporins of III knee)

Escherichia coli (stocks with reduced susceptibility to carbapenems or resistant to carbapenems)

Francise spp.

Campylobacter

Klebsiella pneumoniae (strains with reduced sensitivity to the cephalosporins of III knee)

Klebsiella pneumoniae (strains with reduced susceptibility to carbapenems or resistant to carbapenems)

Leptospira

Mycoplasma pneumoniae

Staphylococcus aureus (strains resistant to methicillin/oxacillin, MRSA)

Staphylococci (strains resistant to vancomycin, VRSA)

Vibrio parahaemolyticus

Yersinia.

Viruses:

Adenoviruses

Astroviruses

Coxsackie viruses

Dengue viruses

Echoviruses

Enteroviruses

Hepatitis D and E viruses

HTL viruses

Influenza viruses

Japanese B encephalitis virus

Calicivirus (containing norovirus)

Parainfluenza viruses

Parvovirus

Wood malvirus (myyric fever virus)

Static encephalitis virus

Respiratory Syncytial virus

Rinovirus

Rotaviruses

Sindbisvirus and

Varicella-zoster virus.

Initial animals:

Cryptosporidium

Cyclospora cayethensis

Entamoeba histolytica

Filariat

Giardia lamblia

Leishmanias

Skistos

Toxoplasma gondii and

Trichinella spiralis.

Mushrooms:

Pneumocystis carinii.

In accordance with Article 23 (2) of the Supply List, microbial strains or samples shall be added to the laboratory's declaration of infection.

General dangerous infectious diseases are:

Escherichia coli EHEC	Strain or sample
Hepatitis A	Sample
Vibrio cholerae	Strain or sample
Corynebacterium diphtheriae	Strain or sample
Salmonella	Strain or sample
Neisseria meningitidis	Strain: findings of blood and spinal fluid
Poliovirus	Strain or sample
Shigellat	Strain or sample
Mycobacterium tuberculosis	Strain or sample

The reported communicable diseases are:

HIV	Strain or sample
Legionella	Strain or sample
Listeria monocytogenes	Strain or sample
Plasmodium	Sample
Haemophilus influenzae	Strain: findings of blood and spinal fluid
Cicodisease virus	Sample
A measles virus	Sample
Vihura virus virus	Sample
Other partici pating micro-tables:
Bacteria
Bordetella pertussis	Strain or sample
Enterobacter cloacae (strains with reduced susceptibility to carbapenems or resistant to carbapenems)	Strain: from any sample
Enter vaccines (VRE)	Strain or sample
Escherichia coli (stocks with reduced susceptibility to carbapenems or resistant to carbapenems)	Strain: from any sample
Klebsiella pneumoniae (strains with reduced susceptibility to carbapenems or resistant to carbapenems)	Strain: from any sample
Staphylococcus aureus (MRSA)	Strain or sample
Staphylococci (strains resistant to vancomycin)	Strain or sample
Streptococcus agalactiae	Strain: findings of blood and spinal fluid
Streptococcus pneumoniae	Strain: findings of blood and spinal fluid
Streptococcus pyogenes	Strain: findings of blood and spinal fluid
Viruses
Enteroviruses (containing coxsackie and enteroviruses)	Strain or sample: findings in faeces
Rotavirus	Strain or sample